New York University
Digital Health Technology
Central Nervous System Disorders
We are a service company that improves medical image quality via advanced post-processing and uses this improvement to develop quantitive biomarkers specific to cellular-level pathology.
Lieven Nuyttens, CEO
Gregory Lemberskiy, CTO